The Immunomodulatory Effect of Sugammadex After Total Hip Replacement Surgery Under Neuraxial Anaesthesia: a Pilot Study
PHASE2CompletedINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
March 21, 2023
Primary Completion Date
November 23, 2023
Study Completion Date
November 23, 2023
Conditions
Innate Inflammatory ResponseOsteoarthritis, Hip
Interventions
DRUG
Sugammadex 100 MG/ML [Bridion]
8 mg/ml
OTHER
Placebo
Sodium 0.9% 5 ml
Trial Locations (1)
6500HB
Radboudumc, Nijmegen
All Listed Sponsors
lead
Radboud University Medical Center
OTHER
NCT05723406 - The Immunomodulatory Effect of Sugammadex After Total Hip Replacement Surgery Under Neuraxial Anaesthesia: a Pilot Study | Biotech Hunter | Biotech Hunter